DVAX [NASD]
Dynavax Technologies Corporation
Index- P/E6.34 EPS (ttm)2.00 Insider Own0.20% Shs Outstand127.58M Perf Week3.08%
Market Cap1.65B Forward P/E- EPS next Y-0.62 Insider Trans-92.33% Shs Float127.26M Perf Month12.87%
Income320.60M PEG- EPS next Q0.32 Inst Own92.70% Short Float / Ratio12.36% / 8.74 Perf Quarter13.47%
Sales733.30M P/S2.25 EPS this Y172.60% Inst Trans-1.85% Short Interest15.73M Perf Half Y4.95%
Book/sh3.94 P/B3.23 EPS next Y-134.40% ROA31.50% Target Price23.20 Perf Year-13.47%
Cash/sh4.53 P/C2.81 EPS next 5Y- ROE89.50% 52W Range7.26 - 17.48 Perf YTD-9.59%
Dividend- P/FCF11.79 EPS past 5Y16.90% ROI29.00% 52W High-27.23% Beta1.34
Dividend %- Quick Ratio3.40 Sales past 5Y108.90% Gross Margin64.70% 52W Low75.21% ATR0.51
Employees311 Current Ratio3.80 Sales Q/Q54.80% Oper. Margin41.10% RSI (14)56.39 Volatility3.95% 4.27%
OptionableYes Debt/Eq0.44 EPS Q/Q273.10% Profit Margin43.70% Rel Volume0.68 Prev Close12.54
ShortableYes LT Debt/Eq0.44 EarningsNov 03 AMC Payout0.00% Avg Volume1.80M Price12.72
Recom1.80 SMA201.40% SMA509.89% SMA2008.24% Volume1,216,494 Change1.44%
Sep-27-22Initiated JMP Securities Mkt Outperform $22
Jan-06-22Resumed Goldman Buy $38
Aug-06-21Initiated Goldman Buy $19
Aug-07-20Reiterated H.C. Wainwright Buy $14 → $12
Aug-03-20Reiterated H.C. Wainwright Buy $12 → $14
Jun-15-20Initiated Evercore ISI Outperform $14
Oct-18-19Initiated H.C. Wainwright Buy $13
Jul-11-19Upgrade Cantor Fitzgerald Neutral → Overweight $20
Feb-27-19Reiterated Cantor Fitzgerald Overweight $32 → $28
May-10-18Upgrade JP Morgan Neutral → Overweight
Show Previous Ratings
Dec-02-22 08:46AM
Nov-30-22 09:10AM
05:28AM
Nov-09-22 04:05PM
05:55AM
12:20PM Loading…
Nov-08-22 12:20PM
09:40AM
Nov-07-22 09:55AM
09:30AM
08:30AM
Nov-06-22 07:22AM
Nov-03-22 10:00PM
07:25PM
Oct-28-22 06:48PM
Oct-25-22 09:30AM
09:35AM Loading…
Oct-24-22 09:35AM
Oct-21-22 09:55AM
06:13AM
Oct-20-22 04:05PM
09:40AM
Oct-14-22 04:05PM
Oct-13-22 06:24PM
Oct-09-22 08:12AM
Oct-07-22 05:42PM
Oct-06-22 09:50AM
Oct-04-22 09:40AM
Sep-28-22 06:15PM
Sep-27-22 06:12PM
Sep-22-22 06:15PM
Sep-20-22 07:29AM
04:43AM Loading…
04:43AM
Sep-19-22 07:43PM
Sep-15-22 11:54AM
09:40AM
Sep-12-22 06:15PM
08:00AM
Sep-10-22 10:53AM
Sep-08-22 04:05PM
Sep-05-22 07:17PM
Aug-30-22 09:35AM
Aug-29-22 07:42PM
Aug-25-22 10:31AM
09:40AM
06:23AM
Aug-12-22 03:45PM
Aug-08-22 09:55AM
09:35AM
Aug-06-22 05:00AM
Aug-05-22 03:43PM
12:20PM
11:41AM
06:59AM
Aug-04-22 06:35PM
04:02PM
09:40AM
Jul-21-22 05:09PM
04:05PM
09:55AM
Jun-30-22 10:50AM
Jun-28-22 07:51AM
Jun-27-22 09:13AM
06:04AM
Jun-23-22 05:04PM
Jun-20-22 07:36AM
Jun-13-22 08:12PM
Jun-05-22 07:13AM
May-25-22 04:05PM
May-21-22 08:49AM
May-20-22 12:53PM
May-19-22 06:01PM
May-16-22 06:46PM
04:10PM
May-13-22 04:17PM
May-12-22 06:16PM
May-08-22 07:31AM
May-06-22 09:01AM
May-05-22 06:05PM
04:02PM
12:08PM
07:00AM
May-04-22 02:25PM
May-03-22 07:20AM
Apr-21-22 04:05PM
Apr-05-22 04:02PM
Apr-03-22 02:55PM
Mar-18-22 09:20AM
Mar-17-22 10:51AM
10:45AM
07:00AM
Mar-08-22 04:05PM
Mar-03-22 04:05PM
Mar-01-22 07:08PM
11:59AM
11:19AM
Feb-28-22 08:30PM
06:05PM
04:02PM
Feb-26-22 06:45AM
Feb-25-22 11:15AM
Feb-24-22 09:05AM
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; agreement with Serum Institute of India Pvt. Ltd.; and sublicense agreement with Merck, Sharp & Dohme Corp. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was incorporated in 1996 and is headquartered in Emeryville, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Novack David FPresident & COONov 08Sale12.4752,204650,9842,066Nov 10 04:54 PM
Hack Andrew A. F.DirectorAug 15Sale14.683,000,00044,040,0005,415,000Aug 17 05:17 PM
Janssen RobertSenior Vice PresidentAug 09Sale16.927,938134,27735,519Aug 10 08:59 PM
Novack David FPresident & COOAug 09Sale16.9226,250444,03753,213Aug 10 08:55 PM
Spencer RyanCEO and DirectorAug 09Sale16.9214,921252,399144,513Aug 10 08:43 PM
CANO FRANCISDirectorAug 08Option Exercise4.9715,00074,55035,834Aug 10 08:21 PM
CANO FRANCISDirectorAug 08Sale17.1715,000257,55020,834Aug 10 08:21 PM
Burgess JustinPrincipal Accounting OfficerMay 17Sale10.006,00060,0003,854May 18 06:16 PM
Novack David FPresident & COOMar 03Sale10.5741,862442,48173,213Mar 04 09:18 PM
Spencer RyanCEO and DirectorMar 03Sale10.5683,108877,923129,771Mar 04 08:16 PM
Burgess JustinPrincipal Accounting OfficerMar 03Sale10.5821,490227,3643,854Mar 04 08:03 PM
Janssen RobertSenior Vice PresidentMar 03Sale10.5724,036253,99824,707Mar 04 08:04 PM
Spencer RyanCEO and DirectorFeb 10Option Exercise0.0089,2500160,839Feb 14 09:09 PM